Number,

Medicine, 

Longevity.

We build precise AI disease models to make high-accuracy predictions of clinical trial outcomes for all diseases.

Sign up now to receive our performance update!

Demiurge has achieved 86.5% (64/74) accuracy in our prospective predictions of the phase 2 and phase 3 clinical trial results in 2020.

86.5%

PREDICTION ACCURACY RATE

as of 30 November 2020

87.5%

PREDICTION ACCURACY RATE

Even for new diseases like COVID-19 without any preexisting clinical data, Demiurge published a detailed COVID-19 disease model in March 2020 (Lovetrue, 2020 here) and has achieved 87.5% accuracy (14/16) in prospective predictions of phase 2 and phase 3 COVID-19 clinical trial results in 2020.

as of 30 November 2020

+41.5%

Demiurge's prediction accuracy has beaten the weighted benchmark by a wide margin of +41.5%.   

as of 30 November 2020

Demiurge
Weighted
Benchmark
45%
86.5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Prediction Accuracy

INDICATIONS

121

Demiurge has made 230+ perspective predictions 
covering 121
 indications in 21 therapeutic areas

21

THERAPEUTIC ARES

as of 30 November 2020

logo front page.png

© 2015-2020 by Demiurge Technologies AG. All Rights Reserved.